Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Doc laments increasing use of P values

    Author:
    HT Staff
    Publish date: March 16, 2016

    Photo by Rhoda Baer A review of the biomedical literature indicates an increase in the use of P values in recent years, but researchers say this...

    • Read More

    News

    Protein plays key role in B-ALL subtype

    Author:
    HT Staff
    Publish date: March 15, 2016

    An RNA binding protein promotes the development of MLL-rearranged B-cell acute lymphoblastic leukemia (B-ALL), according to research published in...

    • Read More

    News

    Idelalisib trials stopped due to AEs

    Author:
    HT Staff
    Publish date: March 15, 2016

    Photo courtesy of Gilead Sciences The US Food and Drug Administration (FDA) has reported that Gilead Sciences, Inc., is stopping 6 clinical...

    • Read More

    News

    Drug granted orphan designation for DLBCL

    Author:
    HT Staff
    Publish date: March 15, 2016

    The US Food and Drug Administration (FDA) has granted orphan designation to the oncology drug candidate PNT2258 for the treatment of diffuse large...

    • Read More

    News

    Intervention helps parents cope with kids’ HSCT

    Author:
    HT Staff
    Publish date: March 15, 2016

    Photo by Chad McNeeley A new social-cognitive intervention can reduce stress in parents of children undergoing hematopoietic stem cell transplant...

    • Read More

    News

    Gut microbes affect platelet function, thrombosis risk

    Author:
    HT Staff
    Publish date: March 14, 2016

    Image by Andre E.X.

    • Read More

    News

    Negative cancer trials have long-term impact

    Author:
    HT Staff
    Publish date: March 14, 2016

    for a clinical trial Photo by Esther Dyson Cancer trials with negative results don’t make an immediate splash in the scientific literature, but...

    • Read More

    News

    AEs prompt EMA review of idelalisib

    Author:
    HT Staff
    Publish date: March 13, 2016

    Photo courtesy of Gilead Sciences, Inc. The European Medicines Agency (EMA) is reviewing the safety of idelalisib (Zydelig), a drug approved to...

    • Read More

    News

    Class of drugs could treat B-cell malignancies

    Author:
    HT Staff
    Publish date: March 12, 2016

    A class of drugs targeting a protein found in the endoplasmic reticulum could be effective against B-cell malignancies, according to a study...

    • Read More

    News

    Allele associated with poor outcome in CLL

    Author:
    HT Staff
    Publish date: March 11, 2016

    A form of the CYP3A7 gene is associated with poor outcomes in chronic lymphocytic leukemia (CLL) and other cancers, according to a study published...

    • Read More

    News

    Product can reduce bleeding in hemophilia B

    Author:
    HT Staff
    Publish date: March 11, 2016

    In a phase 3 study, prophylaxis with the recombinant factor IX product nonacog alfa (BeneFIX) reduced bleeding in patients with hemophilia B....

    • Read More

    News

    Study elucidates MYC’s role in T-ALL

    Author:
    HT Staff
    Publish date: March 11, 2016

    Image by Juha Klefstrom Research has revealed a relationship between the oncogene MYC and 2 cell-surface proteins that protect cancer cells from...

    • Read More

    News

    Program can predict drug side effects

    Author:
    HT Staff
    Publish date: March 11, 2016

    Photo by Darren Baker Scientists say they have developed a computer program that can predict whether or not a given pharmaceutical agent will...

    • Read More

    News

    Regimen can reduce risk of malaria during pregnancy

    Author:
    HT Staff
    Publish date: March 10, 2016

    Photo by Nina Matthews A 2-drug prophylactic regimen can reduce the risk of Plasmodium falciparum malaria during pregnancy, according to a study...

    • Read More

    News

    Intracranial bleeding in older adults on warfarin

    Author:
    HT Staff
    Publish date: March 10, 2016

    Results of a large study suggest warfarin may pose a higher risk of traumatic intracranial bleeding than previously reported, at least among older...

    • Read More

    Pages

    • « first
    • …
    • 128
    • 129
    • 130
    • 131
    • 132
    • 133
    • 134
    • 135
    • 136
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery